Ginwa Enterprise Group Inc (600080) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Ginwa Enterprise Group Inc (600080) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥29.81 Million ≈ $4.36 Million USD) by net assets (CN¥1.58 Billion ≈ $231.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Ginwa Enterprise Group Inc (600080) defensive interval to measure how many days the company can operate on defensive assets alone.
Ginwa Enterprise Group Inc - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Ginwa Enterprise Group Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Ginwa Enterprise Group Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ginwa Enterprise Group Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Profound Medical Corp
TO:PRN
|
-0.142x |
|
Bioteque
TWO:4107
|
0.057x |
|
Allspring Multi Sector Income Fund
NYSE MKT:ERC
|
0.051x |
|
Guanajuato Silver Company Ltd
V:GSVR
|
-0.093x |
|
Izmir Firca Sanayi ve Ticaret
IS:IZFAS
|
0.114x |
|
Sportking India Limited
NSE:SPORTKING
|
0.142x |
|
Tudor Gold Corp
V:TUD
|
-0.003x |
|
PetroVietnam Power Nhon Trach 2 JSC
VN:NT2
|
0.171x |
Annual Cash Flow Conversion Efficiency for Ginwa Enterprise Group Inc (1998–2025)
The table below shows the annual cash flow conversion efficiency of Ginwa Enterprise Group Inc from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see 600080 company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.56 Billion ≈ $228.04 Million |
CN¥24.77 Million ≈ $3.62 Million |
0.016x | +128.23% |
| 2024-12-31 | CN¥1.56 Billion ≈ $228.20 Million |
CN¥10.86 Million ≈ $1.59 Million |
0.007x | -81.16% |
| 2023-12-31 | CN¥1.64 Billion ≈ $239.75 Million |
CN¥60.55 Million ≈ $8.86 Million |
0.037x | +18.34% |
| 2022-12-31 | CN¥1.68 Billion ≈ $246.39 Million |
CN¥52.58 Million ≈ $7.69 Million |
0.031x | +69.04% |
| 2021-12-31 | CN¥1.66 Billion ≈ $242.36 Million |
CN¥30.59 Million ≈ $4.48 Million |
0.018x | -31.70% |
| 2020-12-31 | CN¥1.72 Billion ≈ $251.89 Million |
CN¥46.56 Million ≈ $6.81 Million |
0.027x | -58.36% |
| 2019-12-31 | CN¥1.72 Billion ≈ $251.06 Million |
CN¥111.45 Million ≈ $16.31 Million |
0.065x | +294.35% |
| 2018-12-31 | CN¥1.77 Billion ≈ $259.22 Million |
CN¥29.18 Million ≈ $4.27 Million |
0.016x | -57.02% |
| 2017-12-31 | CN¥1.12 Billion ≈ $163.66 Million |
CN¥42.87 Million ≈ $6.27 Million |
0.038x | -1.25% |
| 2016-12-31 | CN¥1.07 Billion ≈ $157.13 Million |
CN¥41.68 Million ≈ $6.10 Million |
0.039x | +33.85% |
| 2015-12-31 | CN¥1.05 Billion ≈ $153.06 Million |
CN¥30.33 Million ≈ $4.44 Million |
0.029x | -13.83% |
| 2014-12-31 | CN¥1.02 Billion ≈ $149.29 Million |
CN¥34.33 Million ≈ $5.02 Million |
0.034x | -23.57% |
| 2013-12-31 | CN¥998.35 Million ≈ $146.09 Million |
CN¥43.96 Million ≈ $6.43 Million |
0.044x | +132.20% |
| 2012-12-31 | CN¥962.22 Million ≈ $140.80 Million |
CN¥18.25 Million ≈ $2.67 Million |
0.019x | -80.86% |
| 2011-12-31 | CN¥918.45 Million ≈ $134.40 Million |
CN¥91.02 Million ≈ $13.32 Million |
0.099x | +76.26% |
| 2010-12-31 | CN¥724.97 Million ≈ $106.09 Million |
CN¥40.76 Million ≈ $5.96 Million |
0.056x | +3.91% |
| 2009-12-31 | CN¥691.57 Million ≈ $101.20 Million |
CN¥37.42 Million ≈ $5.48 Million |
0.054x | -69.61% |
| 2008-12-31 | CN¥696.22 Million ≈ $101.88 Million |
CN¥123.96 Million ≈ $18.14 Million |
0.178x | +1452.87% |
| 2007-12-31 | CN¥747.13 Million ≈ $109.33 Million |
CN¥-9.83 Million ≈ $-1.44 Million |
-0.013x | -228.44% |
| 2006-12-31 | CN¥702.59 Million ≈ $102.81 Million |
CN¥-2.82 Million ≈ $-411.98K |
-0.004x | +54.64% |
| 2005-12-31 | CN¥781.05 Million ≈ $114.29 Million |
CN¥-6.90 Million ≈ $-1.01 Million |
-0.009x | -109.93% |
| 2004-12-31 | CN¥881.06 Million ≈ $128.93 Million |
CN¥78.36 Million ≈ $11.47 Million |
0.089x | -0.45% |
| 2003-12-31 | CN¥869.84 Million ≈ $127.28 Million |
CN¥77.72 Million ≈ $11.37 Million |
0.089x | +32.72% |
| 2002-12-31 | CN¥850.75 Million ≈ $124.49 Million |
CN¥57.27 Million ≈ $8.38 Million |
0.067x | -30.49% |
| 2001-12-31 | CN¥829.75 Million ≈ $121.42 Million |
CN¥80.36 Million ≈ $11.76 Million |
0.097x | -20.01% |
| 2000-12-31 | CN¥789.96 Million ≈ $115.60 Million |
CN¥95.64 Million ≈ $14.00 Million |
0.121x | -2.80% |
| 1999-12-31 | CN¥480.99 Million ≈ $70.38 Million |
CN¥59.91 Million ≈ $8.77 Million |
0.125x | -2.69% |
| 1998-12-31 | CN¥401.15 Million ≈ $58.70 Million |
CN¥51.35 Million ≈ $7.51 Million |
0.128x | -- |
About Ginwa Enterprise Group Inc
Ginwa Enterprise (Group) Inc. researches, develops, produces, markets, and sells traditional Chinese medicines, biological drugs, and chemical drugs primarily in China. The company offers a range of orthopaedics, immunity, children, and general medicines in various dosage forms, including tablets, capsules, granules, powders, mixtures, oral solutions, syrups, and external solutions. It is also in… Read more